Table-I.
Contrastive Analysis of General Data Between the Study Group and the Control Group (χ̅±S) n=60
| Index | Study group | Control group | t/χ2 | P |
|---|---|---|---|---|
| Age (y) | 62.47±11.92 | 62.08±10.97 | 0.19 | 0.85 |
| Male (%) | 38 (65%) | 35 (62.5%) | 0.31 | 0.57 |
| Clinical stage | 0.21 | 0.65 | ||
| III | 47 (70%) | 49 (75%) | ||
| IV | 13 (30%) | 11 (25%) | ||
| Tumor location | 0.14 | 0.71 | ||
| Peripheral | 38 (67.5%) | 36 (62.5%) | ||
| Central | 22 (32.5%) | 24 (37.5%) | ||
| Pathological type | ||||
| Adenocarcinoma | 32 (57.5%) | 35 (55%) | 0.30 | 0.58 |
| Squamous cell carcinoma | 16 (35%) | 14 (40%) | 0.18 | 0.67 |
| Miscellaneous | 12 (7.5%) | 11 (5%) | 0.05 | 0.82 |
P > 0.05